IceCure Medical Ltd (ICCM)
ICCMNASDAQ-CMMedical/Dental Instruments
$0.7498
-0.0322 (-4.12%) today
Closed, Nov 11, 4:00 PM ET
- Market cap
- $2.59m
- P/E
- –
- EPS, last 4 quarters
- $-8.51
- Dividend yield
- –
- Day range
- –
- 52-week range
- $0.6500 to $22.50
- Average volume
- –
- Previous close
- $0.7820
Analysts
1 coveringBuy1 buy, 0 hold, 0 sell
Targets a year out average $10.00, +1233.7% from here
Earnings
next estimate $-0.8300Next report Nov 18, 2026
Sep 2025
-20.0%
Dec 2025
-50.0%
Mar 2026
-100.0%
Jun 2026
–
estimate reported, and the surprise
Financials
No quarterly figures from the source.
News
8 latest- IceCure Medical Ltd. Granted New Patent in China for Its Cryogenic System ConnectorFintel · 2 days ago
- Natera (NTRA) Reports Q3 Loss, Beats Revenue EstimatesZacks · 6 days ago
- IceCure Secures China NMPA Approval for ProSense Cryoablation SystemZacks · Sep 11, 2026
- IceCure Medical Wins Regulatory Approval To Market ProSense In China RTTNews · Sep 10, 2026
- IceCure Medical Gains IRB Approval For ChoICE Breast Cancer Cryoablation Study As West Cancer Center RTTNews · Aug 20, 2026
- IceCure Medical (ICCM) Q2 2026 Earnings Call TranscriptThe Motley Fool · Aug 19, 2026
- IceCure Reports First Half Of 2026 Results With Strong Revenue Growth RTTNews · Aug 13, 2026
- Pediatrix Medical Group (MD) Beats Q2 Earnings and Revenue EstimatesZacks · Aug 4, 2026
The company
IceCure Medical (Nasdaq: ICCM) develops and markets advanced liquid-nitrogen-based cryoablation therapy systems for the destruction of tumors (benign and cancerous) by freezing, as a safe and effective minimally invasive option to surgical tumor removal, with the primary focus areas being breast, kidney, bone and lung cancer. The Company's flagship ProSense system is marketed and sold worldwide for the indications cleared and approved to date including in the U.S., Europe, and Asia.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Exchange
- NASDAQ-CM
- Region
- Middle East
- Website
- icecure-medical.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.